Go to deals
Private Equity | Business Support Services | Healthcare

CARSO Group has acquired a majority stake in AQCF Group

February 2024 — CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.

Founded in 1992 and hearquartered in France, CARSO Group is one of the leading providers of analytical services in the French market, with activities in neighboring countries. The wide range of analysis offered includes water and environment testing, occupational hygiene and building health, food, genetics and pharma analysis. In 2021, ARCHIMED became CARSO Group’s majority shareholder, in partnership with CAPZA, Siparex, the management team and the founders. Since becoming the majority shareholder, ARCHIMED has supported the company’s organic and external growth across Europe, through mergers and partnerships in the most attractive market segments. The common objective is to strengthen CARSO’s position as an independent, entrepreneurial and international platform in the world of analytical services.

Founded in 2007 and COFRAC-accredited, AQCF Group provides all players in the agri-food sector with its skills and know-how in quality, safety and environmental management, offering a wide range of analysis for food and water quality control, consultancy services in food hygiene and safety, consultancy services in laboratory layout and restructuring, and customized training.

Our role in the transaction

Oaklins’ team in France advised CARSO Group and its shareholders on the acquisition of AQCF Group.

Parties

Talk to the deal team

Armelle Brossard Laborderie

Partner
Paris, France
Oaklins France

Related deals

Comtax has been acquired by Ryan
Private Equity | Business Support Services | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Learn more
Cibus has acquired Aweta from Standard Investment
Private Equity | Agriculture | Industrial Machinery & Components

Cibus has acquired Aweta from Standard Investment

Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.

Learn more
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more